Nikki oversees HemoShear’s drug discovery operations and infrastructure, develops internal processes, recruits staff and specialty service providers, and has designed the company’s state-of-the-art laboratory and office facilities. Dr. Hastings expanded the core HemoShear technology for her doctorate work to investigate phenotypic changes critical to the initiation of vascular disease and was the company’s first employee. Dr. Hastings has a Ph.D. in biomedical engineering from the University of Virginia and a B.S. in biomedical engineering from North Carolina State University. She is an advisory board member for Virginia Bio and supports STEM education initiatives.